VIDEO: People with Parkinson’s freeze for ‘mannequin challenge’
Author: Almaz OhenePublished: 5 January 2017
Prep: Cook: Serves:
Parkinson’s campaigners worldwide are taking up the ‘mannequin challenge’ – the latest social media trend to sweep the web – to show that ‘freezing’ is part of everyday life for many people with the condition
To share the reality of ‘freezing of gait’, major Parkinson’s organisations around the world have filmed their own versions of the popular social media trend, the #MannequinChallenge. Here are three of the most popular – from Parkinson’s UK, the Parkinson Voice Project in the US and Parkinson’s NSW in Australia.
It launched a campaign featuring four videos showing people unable to move in everyday scenarios such as crossing the street, making a cup of tea and answering the front door.
The emotive messaging asks viewers to “Donate. Now. So their challenge can end.”
2. Parkinson Voice Project
Patients at the Parkinson Voice Project’s clinic in Texas, US, showed viewers the interactive and dynamic nature of their regular speech therapy classes, as they pause for a minute for the camera stunt.
3. Parkinson’s NSW
The Australian organisation took a different approach and focused on people with Parkinson’s tremors among those frozen in time.
4. Vlaamse Parkinson Liga
This challenge was an initiative by a group from Ghent, Belgium who are part of the Vlaamse Parkinson Liga (VPL), the Flemish Parkinson’s disease association. They wanted to highlight the fact that although Parkinson’s patients freeze due to stability problems, it’s also difficult to freeze on demand. The organisation’s president is Yves Meersman, who is also the lead chef behind the Parki’s Kookatelier project.
First it was ‘planking’, then came the ice bucket challenge, and now ‘mannequin challenge’ videos are sweeping the web – a viral internet video trend where people remain frozen in action like mannequins while a moving camera films them.
Michael J Fox on his Parkinson’s: “Acceptance isn’t resignation”
MJ Fox and Todd Sherer interviewed for Google talks series
4 weeks ago
Plant-based compounds could treat chronic pain in Parkinson’s, study finds
A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds. The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s. Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s. “Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”
Could playing table tennis help reduce Parkinson’s symptoms?
Researchers at Fukuoka University, Japan, have found that playing table tennis may help alleviate motor symptoms in Parkinson’s. As part of the study, 12 people with Parkinson’s with an average age of 73 played a five-hour session of table tennis every week for a period of six months. The sessions were developed specifically for people with the condition by experienced table tennis players from the university’s department of sports science. The participants were evaluated after three months and at the end of the study. At both evaluations, participants had reduced symptoms – showing improvement in speech, handwriting, walking and hand tremors. Two participants reported side-effects of backache and falling. Study author Ken-ichi Inoue, MD, of Fukuoka University said: “While this study is small, the results are encouraging because they show ping pong, a relatively inexpensive form of therapy, may improve some symptoms of Parkinson’s disease. A much larger study is…
‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s
Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…